A Journal Paper Analysis: A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model Ace myhomework myhomework writers acemywork

Poor pharmacokinetics of FVIII attribute to low subcutaneous bioavailability in the frequent intravenous injections. To overcome the challenges Kitazawa and other develop a humanized bi specific antibody to factors IXa and